DK1708987T3 - L-(-)-moprolol-L-(+)-tartrat - Google Patents
L-(-)-moprolol-L-(+)-tartratInfo
- Publication number
- DK1708987T3 DK1708987T3 DK05701093.6T DK05701093T DK1708987T3 DK 1708987 T3 DK1708987 T3 DK 1708987T3 DK 05701093 T DK05701093 T DK 05701093T DK 1708987 T3 DK1708987 T3 DK 1708987T3
- Authority
- DK
- Denmark
- Prior art keywords
- moprolol
- tartrate
- preparing
- pharmaceutical composition
- tartrate salt
- Prior art date
Links
- 229950001994 levomoprolol Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000145A ITMI20040145A1 (it) | 2004-01-30 | 2004-01-30 | L-moprololo lpiu' tartrato |
| PCT/EP2005/000560 WO2005075408A1 (en) | 2004-01-30 | 2005-01-14 | L-(-)-moprolol l-(+)-tartrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1708987T3 true DK1708987T3 (da) | 2011-06-27 |
Family
ID=34835572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05701093.6T DK1708987T3 (da) | 2004-01-30 | 2005-01-14 | L-(-)-moprolol-L-(+)-tartrat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7524886B2 (da) |
| EP (1) | EP1708987B1 (da) |
| JP (1) | JP4646922B2 (da) |
| KR (1) | KR101122173B1 (da) |
| CN (1) | CN100480232C (da) |
| AT (1) | ATE502003T1 (da) |
| AU (1) | AU2005211458B2 (da) |
| BR (1) | BRPI0507150A (da) |
| CA (1) | CA2550302C (da) |
| DE (1) | DE602005026908D1 (da) |
| DK (1) | DK1708987T3 (da) |
| EA (1) | EA200601402A1 (da) |
| ES (1) | ES2361518T3 (da) |
| HK (1) | HK1093962A1 (da) |
| IL (1) | IL176280A (da) |
| IT (1) | ITMI20040145A1 (da) |
| PL (1) | PL1708987T3 (da) |
| PT (1) | PT1708987E (da) |
| SI (1) | SI1708987T1 (da) |
| WO (1) | WO2005075408A1 (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1211589A (en) * | 1968-08-06 | 1970-11-11 | Ici Ltd | Enantiomer isolation process |
| IT1113029B (it) | 1979-03-01 | 1986-01-20 | Simes | Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro |
| IT1163107B (it) | 1983-02-15 | 1987-04-08 | Simes | Composizioni farmaceutiche e loro uso nel trattamento del glaucoma |
| DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
| AR030414A1 (es) * | 2000-04-03 | 2003-08-20 | Astrazeneca Ab | Combinacion farmaceutica que comprende un beta bloqueante y un inhibidor de hmg-coa reductasa , formulacion farmaceutica, equipo transportable de partes , uso de esta combinacion y de esta formulacion para preparar medicamentos |
-
2004
- 2004-01-30 IT IT000145A patent/ITMI20040145A1/it unknown
-
2005
- 2005-01-14 BR BRPI0507150-0A patent/BRPI0507150A/pt not_active IP Right Cessation
- 2005-01-14 CA CA2550302A patent/CA2550302C/en not_active Expired - Fee Related
- 2005-01-14 US US10/584,261 patent/US7524886B2/en not_active Expired - Fee Related
- 2005-01-14 PL PL05701093T patent/PL1708987T3/pl unknown
- 2005-01-14 SI SI200531291T patent/SI1708987T1/sl unknown
- 2005-01-14 PT PT05701093T patent/PT1708987E/pt unknown
- 2005-01-14 JP JP2006550043A patent/JP4646922B2/ja not_active Expired - Fee Related
- 2005-01-14 DK DK05701093.6T patent/DK1708987T3/da active
- 2005-01-14 AT AT05701093T patent/ATE502003T1/de active
- 2005-01-14 KR KR1020067015321A patent/KR101122173B1/ko not_active IP Right Cessation
- 2005-01-14 ES ES05701093T patent/ES2361518T3/es active Active
- 2005-01-14 EP EP05701093A patent/EP1708987B1/en active Active
- 2005-01-14 WO PCT/EP2005/000560 patent/WO2005075408A1/en active Application Filing
- 2005-01-14 CN CNB2005800023445A patent/CN100480232C/zh not_active Expired - Fee Related
- 2005-01-14 EA EA200601402A patent/EA200601402A1/ru unknown
- 2005-01-14 AU AU2005211458A patent/AU2005211458B2/en not_active Ceased
- 2005-01-14 DE DE602005026908T patent/DE602005026908D1/de active Active
-
2006
- 2006-06-13 IL IL176280A patent/IL176280A/en not_active IP Right Cessation
- 2006-12-27 HK HK06114156.5A patent/HK1093962A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL176280A0 (en) | 2006-10-05 |
| IL176280A (en) | 2010-12-30 |
| ITMI20040145A1 (it) | 2004-04-30 |
| CN1910138A (zh) | 2007-02-07 |
| SI1708987T1 (sl) | 2011-06-30 |
| US20080015258A1 (en) | 2008-01-17 |
| DE602005026908D1 (de) | 2011-04-28 |
| CA2550302A1 (en) | 2005-08-18 |
| JP4646922B2 (ja) | 2011-03-09 |
| AU2005211458A1 (en) | 2005-08-18 |
| JP2007519661A (ja) | 2007-07-19 |
| EA200601402A1 (ru) | 2006-12-29 |
| US7524886B2 (en) | 2009-04-28 |
| WO2005075408A1 (en) | 2005-08-18 |
| ES2361518T3 (es) | 2011-06-17 |
| ATE502003T1 (de) | 2011-04-15 |
| AU2005211458B2 (en) | 2010-06-24 |
| CN100480232C (zh) | 2009-04-22 |
| KR101122173B1 (ko) | 2012-03-15 |
| CA2550302C (en) | 2012-04-24 |
| KR20070000451A (ko) | 2007-01-02 |
| HK1093962A1 (en) | 2007-03-16 |
| EP1708987B1 (en) | 2011-03-16 |
| EP1708987A1 (en) | 2006-10-11 |
| PT1708987E (pt) | 2011-05-31 |
| PL1708987T3 (pl) | 2011-08-31 |
| BRPI0507150A (pt) | 2007-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2020031I1 (no) | kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat | |
| NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
| MX2007002189A (es) | Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos. | |
| CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
| TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
| NO20056132L (no) | Krystallinsk form av beta2 adrenergisk receptoragonist | |
| MXPA05013977A (es) | Metodos y composiciones para tratar enfermedades relacionadas con amiloide. | |
| RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
| EA200800546A1 (ru) | Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk) | |
| BRPI0415164A (pt) | dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador | |
| NO20060535L (no) | Aztreonam-L-lysin og fremgangsmater for fremstilling av dette | |
| MX2007003897A (es) | Una formulacion farmaceutica que comprende insulina cristalina e insulina disuelta. | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| IN2012DN03844A (da) | ||
| TW200638932A (en) | CCI-779 polymorph and use thereof | |
| UA92180C2 (en) | Benzimidazole thiophene compounds as plk inhibitors | |
| EA200501818A1 (ru) | Индазолы, обладающие анальгетической активностью | |
| ATE502003T1 (de) | L-(-)-moprolol-l-(+)-tartrat | |
| CR8955A (es) | Hexadecasacaridos biotinilados, su preparacion y su utilizacion | |
| EA200601117A1 (ru) | Малеат ибопамина, способ его получения и фармацевтические композиции на его основе | |
| ITTO20030850A1 (it) | Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro. | |
| EA200701201A1 (ru) | Новая фармацевтическая композиция для вакцин | |
| UA67614A (en) | Antistress substance |